Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

GlaxoSmithKline - Latest News [Page 1]

Kiwi Parents Urged to Immunise Infants & Teens

Sunday, 11 November 2018, 7:57 pm | GlaxoSmithKline

Kiwi parents of infants, toddlers and adolescents can now immunise their children against the country’s most common type of meningococcal disease (meningococcal B) with the launch of a new vaccine. More >>

New Zealand is closer to eradicating chickenpox

Wednesday, 5 July 2017, 8:49 pm | GlaxoSmithKline

A New Zealand scientist believes that chickenpox, a disease that can lead to serious complications and even death and that causes hundreds of hospitalisations annually, is closer to being eradicated in New Zealand. More >>

New Campaign Featuring King’s High Students & Ben Smith

Monday, 3 July 2017, 6:56 pm | GlaxoSmithKline

New Campaign Featuring King’s High Students & All Black Ben Smith Launches A group of local King’s High School students will appear in a new advertising campaign with All Black Ben Smith, which launches today. More >>

Kiwi Innovations Reflect Pharma Company's Global Index Win

Tuesday, 13 December 2016, 1:13 pm | GlaxoSmithKline

Local innovations from one of NZ’s largest pharmaceutical companies including the translation of asthma materials into te reo Māori, partnerships with aid groups, and increased access to vaccines through reduced pricing are the type of initiatives ... More >>

Maori and Pacific Island Children to Benefit from Vaccine

Wednesday, 17 August 2016, 3:24 pm | GlaxoSmithKline

Maori and Pacific Island children will benefit significantly from the change in formulation of a funded vaccine designed to prevent the most common form of hearing loss among young people, according to a Starship Paediatric Ear Nose and Throat Specialist. More >>

Sensodyne Attempt Guinness World Record

Thursday, 29 January 2015, 10:03 am | GlaxoSmithKline

TITLE FOR THE LARGEST MODEL TOOTH Sensodyne Repair & Protect is set to take a bite at a GUINNESS WORLD RECORDS title at Auckland’s Aotea Square on the morning of Wednesday 4th February. Crowds are expected to gather to witness Sensodyne ... More >>

Update on Varilrix vaccine supply

Thursday, 23 May 2013, 5:25 pm | GlaxoSmithKline

GlaxoSmithKline (GSK) confirmed today that normal supplies of the Varilrix vaccine for the chickenpox virus will be available again within two weeks. More >>

Immunisation Week: thousands of Kiwi kids saved from disease

Monday, 22 April 2013, 4:39 pm | GlaxoSmithKline

While there will always be concerns about how to improve population health, World Immunisation Week is a good time to note New Zealand success in saving thousands of children from serious diseases, Dr Stewart Reid, a general practitioner and former ... More >>

NZ preschoolers get 83000 acute middle ear infections yearly

Thursday, 11 October 2012, 11:29 am | GlaxoSmithKline

A major new study of acute otitis media (AOM), or acute middle ear infection, in New Zealand has reported that there are approximately 83,000 new cases in pre-schoolers every year. More >>

GSK to provide vaccines to target diseases in Fiji

Thursday, 4 October 2012, 9:07 am | GlaxoSmithKline

GSK New Zealand to provide vaccines to target diseases causing high rates of death and illness among Fiji’s women and children More >>

Anna Stove appointed General Manager GlaxoSmithKline NZ

Tuesday, 24 April 2012, 3:06 pm | GlaxoSmithKline

Anna Stove has been appointed General Manager GlaxoSmithKline (GSK) New Zealand, to succeed Geoff McDonald, effective 1 May 2012. Anna, previously Head of Vaccines GSK New Zealand, said she was grateful to Geoff for his leadership and support during ... More >>

Australian national immunisation reduces hospitalisations

Thursday, 8 March 2012, 2:32 pm | GlaxoSmithKline

The effects of a highly contagious virus, which every year causes thousands of New Zealand children to go to hospital have been significantly reduced in Australia according to follow-up research on the roll-out of a new vaccination programme over the last ... More >>

GSK refuses to pay pharmacists for recall work

Wednesday, 22 February 2012, 10:56 am | GlaxoSmithKline

GlaxoSmithKline (GSK) is refusing to pay invoices from community pharmacists for the work done in managing a patient level medicine recall in 2010 – even after GSK lost their case in the district court. More >>

NZ children more at risk of pneumonia

Thursday, 10 November 2011, 12:50 pm | GlaxoSmithKline

World Pneumonia Day gives reason to reflect on the state of the disease in New Zealand and why our children are worse off than children in other developed countries. More >>

Newly funded vaccine offers increased pneumococcal coverage

Friday, 1 July 2011, 11:32 am | GlaxoSmithKline

A newly Government funded pneumococcal vaccine called Synflorix will be rolled out across doctors’ surgeries from 1 July providing increased coverage of pneumococcal disease for New Zealand children. More >>

Medicine Recall – Marevan® (Warfarin) 3mg Tablets

Thursday, 28 January 2010, 4:55 pm | GlaxoSmithKline

Recall of Marevan® (warfarin) 3mg tablets (blue) GlaxoSmithKline New Zealand (GSK), in consultation with Medsafe, is recalling all Marevan (warfarin) 3mg tablets (blue) dispensed to patients since 23 November 2009. More >>

Paracetamol a key to keeping on top of back pain

Monday, 12 October 2009, 10:12 am | GlaxoSmithKline

The best treatment for back pain could be simply something you pick up at the supermarket. That’s the message coming from international pain experts who say everyday paracetamol should be the first line treatment for moderate back pain.1 More >>

Good news for osteoarthritis sufferers

Wednesday, 30 September 2009, 5:31 pm | GlaxoSmithKline

• It used to be called wear and tear arthritis but whatever you call it, osteoarthritis is something that will affect most of us as we age. It’s estimated almost half of those over 60 and nearly all of those over 80 will suffer the joint pain and stiffness ... More >>

New Vaccine to help fight against Cervical Cancer

Tuesday, 29 January 2008, 10:33 am | GlaxoSmithKline

GlaxoSmithKline’s vaccine Cervarix® was approved today by Medsafe for women aged 10-45 years for the prevention of cervical cancer, precancerous lesions and cervical abnormalities caused by Human Papillomavirus (HPV) types 16 and 18. Types 16 and ... More >>

GlaxoSmithKline To Make Vaccine Donation

Wednesday, 20 June 2007, 4:54 pm | GlaxoSmithKline

GlaxoSmithKline (GSK) has announced its intention to donate 50 million doses of H5N1 adjuvanted pre-pandemic influenza vaccine to the World Health Organization (WHO) in support of its stockpile initiative. The donation will help establish a much needed ... More >>





Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.